Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Sell
3,157
-131
-4% -$44.8K 0.03% 267
2026
Q1
$1.16M Sell
3,288
-103
-3% -$36.7K 0.03% 249
2025
Q4
$1.11M Sell
3,391
-70
-2% -$22.2K 0.03% 263
2025
Q3
$977K Sell
3,461
-2,964
-46% -$860K 0.03% 277
2025
Q2
$1.79M Sell
6,425
-322
-5% -$91.2K 0.05% 196
2025
Q1
$2.1M Sell
6,747
-334
-5% -$98.6K 0.07% 155
2024
Q4
$1.85M Buy
+7,081
New +$2.1M 0.06% 168

Other funds holding AMGN

SBI Securities's AMGN Position: Q2 2026 in Review

SBI Securities reduced its Amgen (AMGN) stake by 4% in Q2 2026, selling an estimated $44.8K and leaving 3,157 shares worth $1.14M. The position accounts for 0.03% of the portfolio, ranked #267.

SBI Securities first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.1M in Q1 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SBI Securities held 3,157 shares of Amgen worth $1.14M as of Q2 2026.
  • SBI Securities sold 131 Amgen shares in Q2 2026, an estimated $44.8K.
  • Amgen made up 0.03% of SBI Securities's portfolio in Q2 2026, its #267 holding.
  • SBI Securities first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Amgen position peaked at $2.1M in Q1 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.